Planned to be located at the Biofos waste-water treatment plant, the project is partially-funded through a grant from the Danish Energy Agency (EUDP).

The project will incorporate Akermin’s biocatalyst technology, which can remove carbon dioxide from conventional chemical absorption processes.

Akermin’s technology will incorporate an enzyme that is being developed by Novozymes.

HMN Gashandel will lead the project and oversee the construction as well as operation of the facility.

Danish engineering firm Ammongas will design and build the facility, which will produce grid-quality, bio methane that will be injected into HMN’s distribution network.

The Denmark facility, which is planned to start operations in the second quarter of 2015, is anticipated to be the largest demonstration of a biocatalyst to remove CO2 from an industrial gas stream anywhere in the world.

Akermin president and CEO Barry Blackwell said the project marks the first major step to commercialize the company’s technology for an important market.

"We are very excited to have the opportunity to work with the Partners and with the EUDP to demonstrate how our technology will help reduce the cost to upgrade biogas and enable the cost-effective development of new upgrading facilities with HMN across Denmark, as well as with other partners throughout the world," Blackwell said.